German medical cannabis company Demecan has secured 7 million euros ($7.6 million) in financing to expand production in Europe’s largest medical market. The fresh capital – from btov Partners, a European venture capital firm, and a German single family office – comes as international companies establish footholds in the important European Union market. Constantin von der Groeben, Demecan’s managing director,
German cannabis firm Demecan secures 7 million euros in financing is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
[Read More ...]
Originally posted on German cannabis firm Demecan secures 7 million euros in financing via George Scorsis Medical Marijuana News
No comments:
Post a Comment